Wellington Biomedical Innovation Investors (Cayman) II L.P. — Form D/A
Wellington Biomedical Innovation Investors (Cayman) II L.P. of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-01-06. $192.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-01-06
- Form: D/A
- Accession: 0001903359-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $192.5M
- Investors: 24
- Date of first sale: 2022-01-10
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-428447
Issuer
- Name: Wellington Biomedical Innovation Investors (Cayman) II L.P.
- CIK: 0001903359
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2021
- Address: 280 CONGRESS STREET, BOSTON, MA, 02210
- Phone: 617-951-5000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| N/A WELLINGTON ALTERNATIVE INVESTMENTS LLC | Executive Officer | BOSTON, MA |
| N/A WELLINGTON MANAGEMENT COMPANY LLP | Executive Officer | Boston, MA |
| N/A WELLINGTON MANAGEMENT INVESTMENT, INC. | Executive Officer | BOSTON, MA |
| N/A WELLINGTON ALTERNATIVE INVESTMENTS LLC | Promoter | BOSTON, MA |
| N/A WELLINGTON MANAGEMENT COMPANY LLP | Promoter | Boston, MA |
Other filings by this issuer (1)
More